BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22386032)

  • 1. JCVI response on hepatitis B vaccination.
    Joint Committee on Vaccination and Immunisation
    Lancet; 2012 Mar; 379(9818):803. PubMed ID: 22386032
    [No Abstract]   [Full Text] [Related]  

  • 2. Should universal hepatitis B immunisation be introduced in the UK?
    English P
    Arch Dis Child; 2006 Apr; 91(4):286-9. PubMed ID: 16551785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the best hepatitis B vaccination strategy for South Africa?
    Karim SS
    S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
    [No Abstract]   [Full Text] [Related]  

  • 4. Universal hepatitis B vaccination.
    Kretzschmar M; de Wit A
    Lancet Infect Dis; 2008 Feb; 8(2):85-7; author reply 90. PubMed ID: 18222156
    [No Abstract]   [Full Text] [Related]  

  • 5. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ; Saab S; Meyerhoff AS
    J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Introduction of general hepatitis B vaccination in Switzerland].
    Zimmermann H; Vaudaux B; Kammerlander R
    Soz Praventivmed; 1998; 43 Suppl 1():S65-8, S138-42. PubMed ID: 9833270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse.
    Tyagi V; Singh SK; Sawhney A; Taneja V; Puliyel JM
    Pharmacoeconomics; 2003; 21(7):497-9. PubMed ID: 12696989
    [No Abstract]   [Full Text] [Related]  

  • 8. [Confusing games of public insurance with hepatitis B vaccinations. Interview by Dr. rer. nat. Anita Schweiger].
    Eichhorn R
    Fortschr Med; 1997 Apr; 115(10):41. PubMed ID: 9206686
    [No Abstract]   [Full Text] [Related]  

  • 9. The cost of not implementing routine neonates immunization programmes in HBsAg high prevalence countries.
    Chauvin P; Ekra D; Plotkin SA
    Vaccine; 2002 Jul; 20(23-24):2848-50. PubMed ID: 12126893
    [No Abstract]   [Full Text] [Related]  

  • 10. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK; Hutton G; Das Dores Pascoal E
    Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of running a universal adolescent hepatitis B vaccination programme.
    Wallace LA; Young D; Brown A; Cameron JC; Ahmed S; Duff R; Carman WF; Kitchin NR; Nguyen-Van-Tam JS; Goldberg DJ
    Vaccine; 2005 Dec; 23(48-49):5624-31. PubMed ID: 16099079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of hepatitis B virus immunization.
    Sharfstein J; Wise P
    JAMA; 1996 Mar; 275(12):908; author reply 909. PubMed ID: 8598611
    [No Abstract]   [Full Text] [Related]  

  • 13. 2-dose hepatitis vaccination versus 3-dose regimen.
    Cruess DF
    Pediatrics; 2002 Jun; 109(6):1183; author reply 1183-4. PubMed ID: 12042565
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].
    Wu GY; Gong YL; Yu SL; Shao RT; Qin HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):474-8. PubMed ID: 15231120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desirability and feasibility of hepatitis B vaccine in EPI.
    Mittal SK
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S61-5. PubMed ID: 11411388
    [No Abstract]   [Full Text] [Related]  

  • 16. Disparities in hepatitis B vaccine funding in Australian jurisdictions: limiting access for priority populations.
    MacLachlan JH; Allard NL; Cowie BC
    Aust N Z J Public Health; 2015 Apr; 39(2):192. PubMed ID: 25827189
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of hepatitis B virus immunization.
    Everett WD
    JAMA; 1996 Mar; 275(12):908; author reply 909. PubMed ID: 8598610
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of hepatitis B virus immunization.
    Watters JK; Kral AH
    JAMA; 1996 Mar; 275(12):907-8. PubMed ID: 8598609
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of hepatitis B virus immunization.
    Edmunds WJ; Medley GF; Nokes DJ
    JAMA; 1996 Mar; 275(12):907; author reply 909. PubMed ID: 8598608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.